Center for Clinical Psychiatry, KU Leuven, Leuven, Belgium; Department of Neurosciences, and University Psychiatric Center, KU Leuven, Leuven, Belgium.
Research Group Personal Rights and Property Rights, Faculty of Law, University of Antwerp, Antwerp, Belgium.
Lancet Psychiatry. 2021 May;8(5):444-450. doi: 10.1016/S2215-0366(20)30564-2. Epub 2021 Feb 3.
Psychiatric disorders, and especially severe mental illness, are associated with an increased risk of severe acute respiratory syndrome coronavirus 2 infection and COVID-19-related morbidity and mortality. People with severe mental illness should therefore be prioritised in vaccine allocation strategies. Here, we discuss the risk for worse COVID-19 outcomes in this vulnerable group, the effect of severe mental illness and psychotropic medications on vaccination response, the attitudes of people with severe mental illness towards vaccination, and, the potential barriers to, and possible solutions for, an efficient vaccination programme in this population.
精神障碍,尤其是严重精神疾病,与严重急性呼吸综合征冠状病毒 2 感染以及 COVID-19 相关发病率和死亡率增加有关。因此,应将患有严重精神疾病的人纳入疫苗分配策略的优先考虑对象。在这里,我们讨论了这一弱势群体发生更严重 COVID-19 结局的风险、严重精神疾病和精神药物对疫苗反应的影响、严重精神疾病患者对疫苗接种的态度,以及该人群中有效疫苗接种计划的潜在障碍和可能的解决方案。